Partial nephrectomy through retroperitoneal approach with a new surgical robot system, KD‐SR‐01

Wang, Jie; Fan, Shubo; Shen, Cheng; Yang, Kun‐Lin; Li, Zhihua; Xiong, Shengwei; Meng, Chang; Zhang, Cuijian; Cai, Lin; Zhang, Zhongyuan; Yu, Wei; Dai, Xiaofei; Cui, Liang; Zhang, Zheng; Li, Xuesong; Zhou, Liqun

doi:10.1002/rcs.2352

Cited by 14 publications

(13 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In fact, both robotic transperitoneal dismembered pyeloplasty and robotic partial nephrectomy using the KD-SR-01 system were feasible and safe. 21–24 We believe that transperitoneal PLND could be performed using the KD-SR-01 system safely without pelvic vessel injury, and PLND would be performed further. There were no severe (Clavien–Dindo grade ≥3) perioperative complications or major technical problems, confirming the safety of the KD-SR-01 system.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Robot-Assisted Radical Prostatectomy Using the KangDuo Surgical Robot-01 System: A Prospective, Single-Center, Single-Arm Clinical Study

et al. 2022

Self Cite

View full text Add to dashboard Cite

Purpose:Our goal was to evaluate the feasibility, safety and effectiveness of the KangDuo Surgical Robot-01 (KD-SR-01) system for robot-assisted radical prostatectomy (RARP).Materials and Methods:This prospective, single-center, single-arm clinical study was conducted from May 2021 to August 2021. Sixteen RARP procedures with the KD-SR-01 system were performed by 1 surgeon. The perioperative and followup data were prospectively recorded. Early oncologic outcomes were assessed according to surgical margin status and continence was defined as no more than 1 pad daily or urine leakage of ≤20 gm by the 24-hour pad weight test. Ergonomics were assessed with the NASA-TLX (National Aeronautics and Space Administration Task Load Index).Results:All cases were completed successfully without conversion to traditional RARP, laparoscopic surgery or open surgery. The median docking time, console time and urethrovesical anastomosis time were 5.9 (range, 2.5–11.5), 87 (range, 70–120) and 14.4 minutes (range, 12.0–25.7), respectively. The median estimated blood loss was 50 ml (range, 10–200). None of patients required intraoperative transfusion. The median postoperative hospital stay was 5 days (range, 4–10). Overall, a positive surgical margin occurred in 4 (25%) patients. No biochemical recurrence occurred within 1 month after surgery. The continence rate was 87.5% (14/16) at 1 month after catheter removal. No severe intraoperative or postoperative complications (Clavien–Dindo grade ≥3) occurred. The surgeon reported a high comfort level with a NASA-TLX global score of 22.7±3.2.Conclusions:The KD-SR-01 system is feasible, safe and effective for management of localized prostate cancer.

show abstract

Section: Discussionmentioning

confidence: 99%

“…19,20 The KangDuo Surgical Robot-01 (KD-SR-01) system, which was recently developed in China, has shown promising results for partial nephrectomy and pyeloplasty. 21–24 To our knowledge, this is the first human clinical trial to evaluate the feasibility, safety and efficiency of the KD-SR-01 system for RARP.…”

mentioning

confidence: 99%

Robot-Assisted Radical Prostatectomy Using the KangDuo Surgical Robot-01 System: A Prospective, Single-Center, Single-Arm Clinical Study

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

“…Recently, a domestic robotic platform called KD-SR-01 ® (SuZhou Kang Duo Robot Co., Ltd., Suzhou, China) has been developed. The feasibility, safety and efficacy of KD-SR-01 ® has been confirmed in radical prostatectomy and partial nephrectomy, which additionally provided short docking time and ergonomic benefits (9,10). Nevertheless, its performance in RAPA has not been assessed.…”

Section: Introductionmentioning

confidence: 99%

Feasibility, safety and effectiveness of robot-assisted retroperitoneal partial adrenalectomy with a new robotic surgical system: A prospective clinical study

Dong

Liu

et al. 2023

Front. Surg.

Self Cite

View full text Add to dashboard Cite

ObjectivesTo evaluate the feasibility, safety and efficacy of the newly developed KD-SR-01® robotic system for retroperitoneal partial adrenalectomy.Subjects and MethodsWe prospectively enrolled patients with benign adrenal mass undergoing KD-SR-01® robot-assisted partial adrenalectomy in our institution from November 2020 to May 2022. Surgeries were performed via a retroperitoneal approach using the KD-SR-01® robotic system. The baseline, perioperative and short-term follow-up data were prospectively collected. A descriptive statistical analysis was performed.ResultsA total of 23 patients were enrolled, including nine (39.1%) patients with hormone-active tumors. All patients received partial adrenalectomy via the retroperitoneal approach without conversions to other procedures. The median operative time was 86.5 min [interquartile range (IQR), 60.0–112.5] and the median estimated blood loss was 50 ml (range, 20–400). Three (13.0%) patients developed Clavien-Dindo grade I-II postoperative complications. The median postoperative stay was 4.0 days (IQR, 3.0–5.0). All surgical margins were negative. The short-term follow-up demonstrated complete or partial clinical and biochemical success as well as absence of imaging recurrence in all patients with hormone-active tumors.ConclusionsInitial results illustrate that the KD-SR-01® robotic system is safe, feasible and effective for the surgical management of benign adrenal tumors.

show abstract

“…Recently, a domestic robotic platform called KD-SR-01® (SuZhou Kang Duo Robot Co., Ltd., Suzhou, China) has been developed. The feasibility, safety and e cacy of KD-SR-01® has been con rmed in radical prostatectomy and partial nephrectomy, which additionally provided short docking time and ergonomic bene ts (9,10). Nevertheless, its performance in RAPA has not been assessed.…”

Section: Introductionmentioning

confidence: 99%

Feasibility, Safety and Effectiveness of Robot-assisted Retroperitoneal Partial Adrenalectomy with a new robotic surgical system: A Prospective, Single-Center, Single- Arm Clinical Study

Dong

et al. 2022

Preprint

Self Cite

View full text Add to dashboard Cite

Objectives: To evaluate the feasibility, safety and efficacy of the newly developed KD-SR-01® robotic system for retroperitoneal partial adrenalectomy. Subjects and Methods: We prospectively enrolled patients with benign adrenal mass undergoing KD-SR-01® robot-assisted partial adrenalectomy in our institution from November 2020 to May 2022. Surgeries were performed via a retroperitoneal approach using the KD-SR-01® robotic system. The baseline, perioperative and short-term follow-up data were prospectively collected. A descriptive statistical analysis was performed. Results: A total of 23 patients were enrolled, including nine (39.1%) patients with hormone-active tumors. All patients received partial adrenalectomy via the retroperitoneal approach without conversions to other procedures. The median operative time was 86.5 minutes (interquartile range (IQR), 60.0-112.5) and the median estimated blood loss was 50 mL (range, 20-400). Three (13.0%) patients developed Clavien-Dindo grade I-II postoperative complications. The median postoperative stay was 4.0 days (IQR, 3.0-5.0). All surgical margins were negative. The short-term follow-up demonstrated complete or partial clinical and biochemical success as well as absence of imaging recurrence in all patients with hormone-active tumors. Conclusions: Initial results illustrate that the KD-SR-01® robotic system is safe, feasible and effective for the surgical management of benign adrenal tumors.

show abstract

Partial nephrectomy through retroperitoneal approach with a new surgical robot system, KD‐SR‐01

Cited by 14 publications

References 24 publications

Robot-Assisted Radical Prostatectomy Using the KangDuo Surgical Robot-01 System: A Prospective, Single-Center, Single-Arm Clinical Study

Robot-Assisted Radical Prostatectomy Using the KangDuo Surgical Robot-01 System: A Prospective, Single-Center, Single-Arm Clinical Study

Feasibility, safety and effectiveness of robot-assisted retroperitoneal partial adrenalectomy with a new robotic surgical system: A prospective clinical study

Feasibility, Safety and Effectiveness of Robot-assisted Retroperitoneal Partial Adrenalectomy with a new robotic surgical system: A Prospective, Single-Center, Single- Arm Clinical Study

Contact Info

Product

Resources

About